Zhexuan Wang
15 West Changle Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆.
Journal: JHEP reports : innovation in hepatology
Published: December 15, 2023
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.
Journal: European radiology
Published: September 23, 2021
Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS.
Journal: JHEP reports : innovation in hepatology
Published: July 17, 2021
Long-term survival prediction for transjugular intrahepatic portosystemic shunt in severe cirrhotic ascites: assessment of ten prognostic models.
Journal: European journal of gastroenterology & hepatology
Published: September 02, 2020
Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma.
Journal: Annals of translational medicine
Published: May 16, 2020
Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial.
Journal: The lancet. Gastroenterology & hepatology
Published: March 01, 2019
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC.
Journal: Investigational new drugs
Published: June 16, 2018
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study.
Journal: Journal of hepatology
Published: June 16, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026